Contingency Management in Substance Abuse Treatment
Edited by Stephen T. Higgins, Kenneth Silverman, and Sarah H. Heil
Foreword by Joseph V. Brady
Hardcover
Hardcover
orderSeptember 26, 2007
ISBN 9781593855710
Price: $62.00 380 Pages
Size: 6" x 9"
Timely and authoritative, this volume brings together leading clinical researchers to describe contemporary applications of contingency management principles across a wide range of substance use disorders and patient populations. Contingency management uses a system of incentives and disincentives to motivate patients to meet their treatment goals, and has been implemented successfully in community treatment clinics, drug courts, and other settings. Featuring illustrative case material, the book presents a cogent empirical rationale and practical strategies for targeting major drugs of abuse and working with specific populations, including adolescents, pregnant women, and dually diagnosed and homeless individuals. Also addressed are the nuts and bolts of developing and funding contingency management programs.
“Leadership and management in the field of addiction should read this book to understand when, where, and how contingency management is and is not effective.”
—Journal of Clinical Psychiatry
“This book provides a useful and informative compilation of the empirical base for contingency management across numerous substances of abuse, populations, and types of settings. It is comprehensive and up to date. Concerns and issues are excellently handled, and the introduction provides an exceptionally fine overview. Discussion of issues in disseminating the approach to community settings is particularly interesting, although complexity and cost remain major deterrents. Anyone who plans to use contingency management in research would benefit from having this reference.”
—Social Service Review
“Presents a solid evidence base for the application of contingency management in a variety of settings and with a range of different client types....This book will suit a range of clinicians and researchers from the alcohol and drug sector....This book will help novice readers and more experienced researchers and clinicians to think about and clarify their thinking around contingency management. The book presents compelling evidence, both positive and negative, and makes recommendations regarding future research, and while the focus is primarily in the research arena there is enough to hold the interest of any clinician interested in exploring contingency management for their own work-place.”
—Drug and Alcohol Review
“The book is very well written, informative, and enjoyable to read....One chapter reads as a 'how to' manual designed to assist the practitioner in implementation of this approach within his/her own practice. As a result, upon completion of the book, most psychologists in applied practice would likely feel confident in their ability to utilize contingency management techniques/programs with their own patients. This volume would be a useful resource for any researcher or practitioner in the area of substance abuse treatment.”
—PsycCRITIQUES
“Each chapter in the book can be used by itself, or as a whole. Potential audience for the book is wide; individuals including rehabilitation counselors, mental health counselors, psychologists, addiction specialists, social workers, criminal justice majors, attorneys, and judges would all benefit from reading it. Additionally, it could be used in upper-level undergraduate, graduate, and continuing education courses. The editors and authors are to be congratulated for applying basic principles of behavior science to the creative treatment of an entire array of addictions. This book shines the way toward more research in the interventions and findings that will emerge from that study toward best practices in the treatment of addictive behaviors in many populations and settings.”
—Journal of Applied Rehabilitation Counseling
“This book provides the most up-to-date summary of the broad range of applications of contingency management for substance abuse. Many practical examples bring to life the conceptual and empirical underpinnings of the approach. Well organized and comprehensive, this is a most useful text for training practitioners and students in an important therapeutic technique.”
—Thomas R. Kosten, MD, Jay H. Waggoner Chair and Professor of Psychiatry and Neuroscience, Baylor College of Medicine
“This volume constitutes the state of the art of one of the most effective empirically based therapies for addiction. The contributors clearly lay out the fundamental approach, the breadth and depth of the application, and the utility of this treatment for addiction in its many forms. In my view, this book should be required reading for students, professionals working with addiction, and scientists.”
—Warren K. Bickel, PhD, Director, Center for Addiction Research, University of Arkansas for Medical Sciences
“This well-written book offers a comprehensive overview of contingency management. The authors provide evidence-based information on the treatment of a wide range of substance use disorders in different populations and treatment settings. The coverage of dissemination issues is very welcome. Highly recommended for all those working in the field of addiction or psychiatry, from students to experienced clinicians.”
—Cor A.J. de Jong, MD, PhD, Nijmegen Institute for Scientist-Practitioners in Addiction, Radboud University Nijmegen, The Netherlands
“If a new addiction medication were developed that produced results comparable to contingency management, the FDA would approve it enthusiastically and drug companies would pay big dollars to own the patent. This book makes it crystal clear just how powerful contingency management is, how easy it is to use, and how well it works across diverse populations, problems, and settings. Like Marlatt and Gordon's Relapse Prevention and Miller and Rollnick's Motivational Interviewing, this is a seminal volume on psychological/behavioral addiction treatment. The book will be valuable in undergraduate psychology classes, graduate programs on addiction, and clinical psychology training programs. It is also a very valuable research resource.”
—Richard A. Rawson, PhD, Associate Director, Integrated Substance Abuse Programs, University of California at Los Angeles
“This book reflects the depth and variety of applications of the contingency management approach. The chapters are unified by basic CM principles and cover a wide range of settings and populations. It can be used as a classroom text at the graduate level or in specialty addiction training programs. With authors well known for their specific expertise, this is an excellent source for those seeking a review of evidence-based principles and interventions.”
—Joan E. Zweben, PhD, Department of Psychiatry, University of California, San Francisco; staff psychologist, San Francisco VA Medical Center
Table of Contents
1. Introduction, Stephen T. Higgins and Kenneth Silverman
I. Contingency Management Across Substances
2. Cocaine, Stephen T. Higgins, Sarah H. Heil, Randall E. Rogers, and Laura Chivers
3. Opioids, David H. Epstein and Kenzie L. Preston
4. Marijuana, Alan J. Budney and Catherine Stanger
5. Methamphetamines, John M. Roll and Thomas Newton
6. Tobacco, Stacey C. Sigmon, Richard J. Lamb, and Jesse Dallery
7. Alcohol, Conrad J. Wong, Kenneth Silverman, and George E. Bigelow
8. Medication Compliance, Bruce J. Rounsaville, Marc Rosen, and Kathleen M. Carroll
II. Special Populations
9. Homeless Populations, Jesse B. Milby and Joseph Schumacher
10. Pregnant and Postpartum Women, Sarah H. Heil. Jin H. Yoon, and Stephen T. Higgins
11. People with Mental Illness, Jennifer W. Tidey and Rick Ries
12. Adolescents, Suchitra Krishnan-Sarin, Amy M. Duhig, and DanaA.Cavallo
III. Dissemination
13. Large-Scale Dissemination Efforts in Drug Abuse Treatment Clinics, Maxine L. Stitzer and Scott Kellogg
14. Lowering Costs in Drug Abuse Treatment Clinics, Nancy M. Petry and Sheila M. Alessi
15. Use of Community Donations and Clinic Rebates to Fund Contingency Management in Community Treatment Clinics, Leslie Amass and Jonathan B. Kamien
16. Contingency Management in an Entitlement Rehabilitation Setting: An Example from the Veterans Health Administration, Charles Drebing, Bruce J. Rounsaville, and Robert Rosenheck
17. Employment-Based Reinforcement in the Treatment of Drug Addiction, Wendy D. Donlin, Todd W. Knealing, and Kenneth Silverman
18. Contingency Management in Adult Criminal Drug Courts, Douglas B. Marlowe and Conrad J. Wong
About the Editors
Stephen T. Higgins, PhD, is Professor of Psychiatry and Psychology at the University of Vermont. The recipient of numerous national awards for research excellence, Dr. Higgins is currently President of the College on Problems of Drug Dependence and principal and coinvestigator on numerous grants from the National Institute on Drug Abuse (NIDA). He has published extensively on furthering scientific understanding of the behavioral and pharmacological processes involved in substance use disorders.Kenneth Silverman, PhD, served as a staff fellow in the Clinical Trials Section of NIDA’s Intramural Research Program in Baltimore from 1991 to 1993. He is currently Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. Dr. Silverman’s research focuses on developing operant treatments to address the interrelated problems of poverty and drug addiction. His primary research has focused on the development and evaluation of abstinence reinforcement interventions for heroin and cocaine addiction in poor, inner-city adults, and the integration of those abstinence reinforcement contingencies into model employment settings.
Sarah H. Heil, PhD, is Research Assistant Professor of Psychiatry and Psychology at the University of Vermont. Her research interests include the behavioral and pharmacological processes involved in substance use disorders, with a special focus on pregnant and recently postpartum women. She is a regular contributor to the scientific literature on drug abuse and has received several honors and awards for research excellence.
Contributors
Sheila M. Alessi, PhD, Department of Psychiatry, University of Connecticut Health Center, Storrs, ConnecticutLeslie Amass, PhD, Schering Plough Global Medical Affairs, Kenilworth, New Jersey
George E. Bigelow, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Alan J. Budney, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Kathleen M. Carroll, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Dana A. Cavallo, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Laura Chivers, MA, Department of Psychology, Harvard University, Cambridge, Massachusetts
Jesse Dallery, PhD, Department of Psychology, University of Florida, Gainesville, Florida
Wendy D. Donlin, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Charles Drebing, PhD, New England Mental Illness Research Education and Clinical Center, Bedford VA Medical Center, Bedford, Massachusetts
Amy M. Duhig, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
David H. Epstein, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Sarah H. Heil, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Stephen T. Higgins, PhD, Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont
Jonathan B. Kamien, PhD, BioPsych Consulting, Califon, New Jersey
Scott Kellogg, PhD, Department of Psychology, New York University, New York, New York
Todd W. Knealing, PhD, Department of Psychology, Briarcliff University, Sioux City, Iowa
Suchitra Krishnan-Sarin, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Richard J. Lamb, PhD, Departments of Psychiatry and Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
Douglas B. Marlowe, JD, PhD, Treatment Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
Jesse B. Milby PhD, Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama
Thomas Newton, MD, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
Nancy M. Petry, PhD, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut
Kenzie L. Preston, PhD, Clinical Pharmacology and Therapeutics Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
Richard K. Ries, MD, Department of Psychiatry and Behavioral Sciences, University of Washington, and Harborview Medical Center, Seattle, Washington
Randall E. Rogers, PhD, Substance Abuse Treatment Center, Burlington, Vermont
John M. Roll, PhD, Washington Institute for Mental Illness Research and Training, Washington State University, Spokane, Washington
Marc Rosen, MD, Department of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut
Robert Rosenheck, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Bruce J. Rounsaville, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
Joseph Schumacher, PhD, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama
Stacey C. Sigmon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont
Kenneth Silverman, PhD, Center for Learning and Health, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Catherine Stanger, PhD, Center for Addiction Research, Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
Maxine L. Stitzer, PhD, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Jennifer W. Tidey, PhD, Center for Alcohol and Addiction Studies, and Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island
Conrad J. Wong, PhD, Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky
Jin H. Yoon, PhD, Department of Psychiatry, University of Vermont, Burlington, Vermont